If you have been reading about regulatory status and want a single page that covers the useful parts, this is it: definitions, context, how it is studied, and the questions that come up repeatedly.
Updated 2026-04-04. Numbers and descriptions here follow the published literature rather than marketing material.
Analytical characterization of AOD-9604 typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) to assess purity and identity. Mass spectrometry provides confirmation of molecular mass, while amino acid analysis can verify composition. These methods are standard for peptide research chemicals. Because the peptide lacks a distinct chromophore, detection often relies on ultraviolet absorbance at 214 nm or mass spectrometric response. Laboratories may also use capillary electrophoresis for separation. For example, size-exclusion chromatography can detect aggregates.
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.
Development of AOD-9604 began in the 1990s as scientists sought to isolate metabolic effects of growth hormone without its growth-promoting actions. Early laboratory work focused on fat cells and animal models. Several human trials followed, examining changes in body composition and fat mass. Results have been mixed, and the peptide has not progressed to widespread clinical approval. Interest continues in research settings, particularly regarding its mechanism and potential metabolic targets.
Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized form |
| Solubility | Soluble in water | Also soluble in aqueous buffers |
| Storage temperature | -20°C or below | Protect from light and moisture |
| Analytical method | RP-HPLC | Purity and identity assessment |
| Mass confirmation | Mass spectrometry | Verifies molecular mass |
Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.
AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.
Identity and purity are usually assessed with reversed-phase high-performance liquid chromatography and mass spectrometry. Reversed-phase HPLC separates the peptide from related impurities and can estimate purity by ultraviolet absorbance, while mass spectrometry confirms the molecular mass and detects modifications. Peptide mapping, amino acid analysis, and disulfide mapping may be used when the sequence or disulfide arrangement must be verified. Because AOD9604 contains cysteine residues, oxidation and disulfide isomers are possible quality concerns in synthetic batches.
Clinical development of AOD9604 included trials in people with obesity, but the results did not lead to approval as a prescription medicine in major markets. Interest later shifted to research settings and to unapproved products marketed for body composition. Regulatory agencies have questioned whether the peptide qualifies as a dietary ingredient, and some have issued warnings about its presence in supplements. Long-term human safety data are limited, and questions about efficacy, dosing, and target populations remain unresolved.
AOD9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to a short sequence near the end of the 191-amino-acid hormone, often described as residues 176–191 or a related fragment. Researchers designed it to separate metabolic effects from the growth-promoting actions of full-length growth hormone. Early work in the 1990s explored it as a candidate for weight and lipid disorders. It is not a naturally circulating hormone fragment produced in large amounts.
A central uncertainty is whether observed metabolic changes translate into meaningful clinical benefits. Study designs vary in dose, duration, and participant characteristics, making comparisons difficult. Independent replication is limited, and the field lacks consensus on optimal endpoints or treatment duration. Ongoing or future studies may clarify mechanism and effect size, but current evidence does not establish a clear therapeutic role. Researchers often call for larger, longer, and better-controlled trials, while questions remain about which patient groups might respond.
Proposed mechanism focuses on lipolysis, the breakdown of stored triglycerides into free fatty acids and glycerol. AOD-9604 is thought to act on adipose tissue without stimulating appetite or affecting blood sugar in the same way as growth hormone. Laboratory studies report increased fat oxidation in some models. The precise receptor interactions and signaling pathways remain incompletely characterized. Researchers have proposed that the peptide may influence fat mobilization through pathways distinct from the full hormone.
Research has examined whether the peptide affects fat mass independently of growth hormone's other actions. Early animal studies suggested reductions in body fat, but species differences and small sample sizes limit interpretation. Human studies have generally been short and have not consistently shown large effects. Some trials measured body composition, lipid profiles, and safety parameters, but the overall picture is one of suggestive yet inconclusive metabolic activity. Findings vary across study populations and protocols.
In 1972, eight remarkably preserved mummies were discovered at an abandoned Inuit settlement called Qilakitsoq, in Greenland. The "Greenland Mummies" consisted of a six-month-old baby, a four-year-old boy, and six women of various ages, who died around 500 years ago. Their bodies were naturally mummified by the sub-zero temperatures and dry winds in the cave in which they were found.
As lieutenant governor in 2016, Newsom was the official proponent of Proposition 63. The ballot measure required a background check and California Department of Justice authorization to purchase ammunition, among other gun control regulations. In response to the 2019 mass shooting in Virginia Beach, Newsom called for nationwide background checks on people purchasing ammunition. Later that year, he responded to the Gilroy Garlic Festival shooting by stating his support for the Second Amendment and saying he would like national cooperation controlling "weapons of goddamned mass destruction". He also said, "These shootings overwhelmingly, almost exclusively, are males, boys, 'men'—I put in loose quotes. I do think that is missing in the national conversation." On June 10, 2021, Newsom called federal Judge Roger Benitez "a stone cold ideologue" and "a wholly owned subsidiary of the gun lobby of the National Rifle Association" after Benitez struck down California's statewide ban on assault weapons. While the ban remained in place as the state appealed the ruling, Newsom proposed legislation that would empower private citizens to enforce the ban after the United States Supreme Court declined to strike down the Texas Heartbeat Act, which empowers private citizens to report unauthorized abortions. In 2022, Newsom signed gun control bills passed by the California Legislature.
The player must explore others houses and buildings around the map to find food and water to avoid starving and dehydrating, which will end the game (if on permadeath mode; otherwise, they will respawn back at the last hatch they visited.) The Night Watch mode focuses on the game's combat features and instead of being a downer, the player plays as a Bobby named John Constable (or "Constable Constable" for short). The player spawns on a randomly generated island in the Village of Hamlyn, with no bridges leading off of the island. The mode is round-based, and to advance the rounds, the player must eliminate all enemies that spawn in until the rounds timer ends, in which the player can use a Bobby Popper to end the round. The player earns money (pounds) by eliminating enemies, consisting of Downers, "Headboys", Plaguies, and Wastrels. Witches can spawn, serving as mini-bosses and dealing the most damage out of any enemy, but also give major rewards when defeated. As well as spending their money on vending machines to gain better gear and items, players must spend their money on Joy, which they need to do regularly as their Joy Meter goes down. If the player character run out of Joy, the game ends. Joy starts at £20, but the price goes up every round. The player always takes Blackberry Flavour of Joy, a rarer version of the drug exclusively made for the Bobbies. As the player defeats enemies, their Rage Meter grows, with one slot of it being filled per elimination.
In February 2025, Bukele offered Secretary of State Rubio to accept non-Salvadoran deportees from the United States, including convicted American prisoners "of U.S. citizenship and legal residents". Rubio described the offer as the "most unprecedented and extraordinary migratory agreement anywhere in the world". Bukele stated that these "dangerous American criminals" would be incarcerated in CECOT. In March 2025, the United States deported 238 alleged members of the Venezuelan gang Tren de Aragua to El Salvador. Bukele met Trump in the Oval Office in April 2025 where they discussed immigration. Both Trump and Bukele stated they could not unilaterally release Kilmar Abrego Garcia, a migrant deported due to an administrative error.
Sources: en.wikipedia.org
Membrane blebbing: The cell membrane shows irregular buds known as blebs. Initially these are smaller surface blebs. Later these can grow into larger so-called dynamic membrane blebs. An important regulator of apoptotic cell membrane blebbing is ROCK1 (rho associated coiled-coil-containing protein kinase 1). Formation of membrane protrusions: Some cell types, under specific conditions, may develop different types of long, thin extensions of the cell membrane called membrane protrusions. Three types have been described: microtubule spikes, apoptopodia (feet of death), and beaded apoptopodia (the latter having a beads-on-a-string appearance). Pannexin 1 is an important component of membrane channels involved in the formation of apoptopodia and beaded apoptopodia. Fragmentation: The cell breaks apart into multiple vesicles called apoptotic bodies, which undergo phagocytosis. The plasma membrane protrusions may help bring apoptotic bodies closer to phagocytes.
234U has a neutron capture cross section of about 100 barns for thermal neutrons, and about 700 barns for its resonance integral—the average over neutrons having various intermediate energies. In a nuclear reactor, non-fissile isotopes capture a neutron breeding fissile isotopes. 234U is converted to 235U more easily and therefore at a greater rate than uranium-238 is to plutonium-239 (via neptunium-239), because 238U has a much smaller neutron-capture cross section of just 2.7 barns.
As of 2025, many companies are researching and manufacturing new insulin analogues. These insulins are usually designed to be either ultra-short-acting or ultra-long-acting. Insulin degludec, an ultra-long-acting insulin analog, was developed by Novo Nordisk and approved by the FDA in 2015. Insulin degludec has an extended duration of action, lasting up to 42 hours, offering greater flexibility in dosing schedules. In March 2024, insulin icodec was approved for medical use in Canada. The same month, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion, recommending the granting of marketing authorization for Awiqli, under which insulin icodec is marketed. Following the CHMP's recommendation, insulin icodec was approved for medical use in the European Union in May 2024. Insulin icodec has a plasma half-life more than eight days (compared to 25 hours of the previous longest-acting insulin analogue insulin degludec), making it a once-weekly basal insulin.
Edelman, Under Secretary of Defense for Policy, described the shelling of the Georgian villages in hearing of the United States Senate Committee on Armed Services and said that Russian peacekeepers neglected their obligation to curb artillery fire and that Georgian military began to quell artillery sites in South Ossetia on the night of 7 August. Edelman said that although Russian officials had claimed that Russia's goal was defense of Russian citizens and peacekeepers, "What became clear is there never seemed to be a limit to Russia's operational – nor strategic – aims." Edelman said that the Russian invasion was pre-planned. According to Edelman, although Putin had blamed the United States for arming Georgia, the United States had never intended for the Georgian forces to oppose Russia. Edelman further stated, "Russia was clearly adding to tension in order to provoke a Georgian response." Edelman said that the first modern Russian invasion of foreign country "sends a chilling message" about new Russian foreign policy. In September 2008, Dana Rohrabacher (a senior Republican member of the United States House of Representatives) argued at a United States House Committee on Foreign Affairs meeting that Georgia started the fighting on August 7, citing alleged unnamed intelligence reports. Telegraph noted the Russian media paid much attention to Rohrabacher's remarks. In September 2008, Senator Hillary Clinton proposed to create a U.S. commission to study the war.
== Effects against senescent cells == In animal studies, navitoclax was found to be a senolytic agent, inducing apoptosis in senescent, but not non-senescent cells. Oral administration of navitoclax (ABT-263) to either sublethally irradiated or normally aged mice reduced senescent cells, including senescent bone marrow hematopoietic stem cells and senescent muscle stem cells. This depletion mitigated total-body irradiation-induced premature aging of the hematopoietic system and rejuvenated the aged hematopoietic stem cells and muscle stem cells in normally aged mice. On September 19, 2018, an article was published in Nature about using navitoclax to kill senescent glial cells in mice. The drug had a protective effect against memory loss in mice genetically engineered to simulate Alzheimer's disease. On December 3, 2024, an article was published in Aging detailing a study investigating the effects of topical navitoclax (ABT-263) on aged mouse skin. It examined whether eliminating senescent cells could improve wound healing. In the study, 24-month-old mice were treated with topical navitoclax (ABT-263) for five days. The treatment reduced the expression of senescence markers p16 and p21 and decreased the number of SA-β-gal– and p21-positive cells compared with DMSO controls. Navitoclax (ABT-263) application also induced a transient inflammatory response and macrophage infiltration. Bulk RNA sequencing revealed upregulation of genes involved in wound-healing pathways, including inflammation, angiogenesis, collagen synthesis, and extracellular matrix remodeling.
Sources: en.wikipedia.org
=== Films depicting Cold War espionage === Tinker Tailor Soldier Spy is a 2011 Cold War spy thriller adaptation of the 1974 John le Carré novel of the same name. It is set in London in the early 1970s and follows the hunt for a Soviet double agent at the top of the British secret service. The Spy Who Came In from the Cold is a 1965 British Cold War spy film based on the 1963 John le Carré novel. The film depicts a British agent's mission as a faux defector to East Germany to sow damaging disinformation about a powerful East German intelligence officer. Firefox is a 1982 film based on a Craig Thomas novel of the same name. The plot details an American plot to steal a highly advanced Soviet fighter aircraft (MiG-31 Firefox) which is capable of Mach 6, is invisible to radar, and carries weapons controlled by thought. The Hunt for Red October is a 1990 film based on the 1984 Tom Clancy novel of the same name about the captain of a technologically advanced Soviet ballistic missile submarine that attempts to defect to the United States. James Bond first appeared in 1953. While the primary antagonists in the majority of the novels were Soviet agents, the films were only vaguely based on the Cold War. The Bond movies followed the political climate of the time in their depictions of Soviets and "Red" Chinese.
=== GDP growth rate === In the first quarter of 2025, economic growth was a negative 0.5%. CBS News said the decline occurred because "businesses scrambled to bring in foreign goods ahead of new U.S. tariffs". Second quarter economic growth was 3.8% annualized (as if continuing for the full year). In the third quarter, real GDP grew to 4.3%, the fastest rate in two years.
=== 2010 Pandemrix connected with narcolepsy === The Pandemrix influenza vaccine was developed by GlaxoSmithKline in 2006. It was used by Finland and Sweden in the H1N1 mass vaccination of the population against the 2009 swine flu pandemic. In August 2010, The Swedish Medical Products Agency (MPA) and The Finnish National Institute for Health and Welfare (THL) launched investigations regarding the development of narcolepsy as a possible side effect to Pandemrix flu vaccination in children, and found a 6.6-fold increased risk among children and youths, resulting in 3.6 additional cases of narcolepsy per 100,000 vaccinated subjects. In February 2011, The Finnish National Institute for Health and Welfare (THL) concluded that there is a clear connection between the Pandemrix vaccination campaign of 2009 and 2010, and the narcolepsy epidemic in Finland. A total of 152 cases of narcolepsy were found in Finland during 2009–2010, and ninety per cent of them had received the Pandemrix vaccination. Sweden however observed very few influenza cases totally in 2009 and especially 2010 as compared to most other years. In 2015, it was reported that the British Department of Health was paying for Sodium oxybate medication for 80 patients who are taking legal action over problems linked to the use of the swine flu vaccine, at a cost to the government of £12,000 per patient per year.
=== Automated fast-flow synthesis of biopolymers === The Pentelute laboratory designs fully automated fast-flow machines to accelerate the chemical manufacture of sequence-defined biopolymers. It has built an efficient machine that can produce amide bonds an order of magnitude faster than commercially available instruments. The machine is inspired by Nature's ribosome that can make proteins in minutes. While the Pentelute group's fast-flow technology is not as fast as the ribosome, it can form one amide bond in 7 seconds. This technology not only facilitates rapid polypeptide generation but it has enabled the group to carry out entire D-scans of proteins to investigate folding and functions. This technology was used to achieve stepwise total chemical synthesis of functional protein chains and was adapted to produce phosphorodiamidate morpholino oligomers (PMO) in flow. Automated flow technology may be used to solve the manufacturing problem for on-demand personalized therapies, such as cancer vaccines, and to design engineered biologics, such as dimeric transcription factor mimetics.
The history of sertraline dates to the early 1970s when Pfizer chemist Reinhard Sarges invented a novel series of psychoactive compounds, including lometraline, based on the structures of the neuroleptics thiothixene and pinoxepin. Further work on these compounds led to tametraline, a norepinephrine and weaker dopamine reuptake inhibitor. Development of tametraline was soon stopped because of undesired stimulant effects observed in animals. A few years later, in 1977, pharmacologist Kenneth Koe, after comparing the structural features of a variety of reuptake inhibitors, became interested in the tametraline series. He asked another Pfizer chemist, Willard Welch, to synthesize some previously unexplored tametraline derivatives. Welch generated several potent norepinephrine and triple reuptake inhibitors, but to the surprise of the scientists, one representative of the generally inactive cis-analogs was a serotonin reuptake inhibitor. Welch then prepared stereoisomers of this compound, which were tested in vivo by animal behavioral scientist Albert Weissman. The most potent and selective (+)-isomer was taken into further development and eventually named sertraline. Weissman and Koe recalled that the group did not set up to produce an antidepressant of the SSRI type—in that sense their inquiry was not "very goal driven", and the invention of the sertraline molecule was serendipitous. According to Welch, they worked outside the mainstream at Pfizer, and even "did not have a formal project team".
Sources: en.wikipedia.org
Reversed-phase HPLC is used to assess purity, and mass spectrometry confirms molecular mass. Amino acid analysis can verify composition. These methods are standard for peptide characterization.
Lyophilized powder should be stored at -20°C or lower, protected from light and moisture. Reconstituted solutions are less stable and should be aliquoted to avoid freeze-thaw cycles. Always follow supplier instructions.
Variability in purity, counterion content, and residual solvents is possible. Independent testing and certificates of analysis help verify quality. Microbial contamination can occur if handling is not sterile.
AOD-9604 is a synthetic peptide fragment of human growth hormone, corresponding to amino acids 176-191. It is studied for potential effects on fat metabolism, but it is not approved as a drug in most countries. Its exact mechanism remains under investigation.